AnaSCI - Fitness Evolved

Buy Needles and Syringes with NO PRESCRIPTION   Synthetek Muscle Building And Fat Loss Products   Cheap Pure Supplements

ŠALL CONTENT OF THIS WEBSITE IS COPYRIGHTED AND CANNOT BE REPRODUCED WITHOUT THE ADMINISTRATORS CONSENT 2003-2019

   
  Synthetek Syntherol  
   
   
   
Largest Selection of Bodybuilding Products   Largest Selection of Bodybuilding Products   Largest Selection of Bodybuilding Products


User CP FAQ Members List Calendar New Posts Quick Links Log Out

AnaSCI Fitness Evolved  AnaSCI Fitness Evolved  AnaSCI Fitness Evolved  AnaSCI Fitness Evolved  AnaSCI Fitness Evolved


        
        
        
        
        

Automatic Translations (Powered by Yandex):
Albanian Belarusian Catalan Czech Danish Dutch English Estonian Finnish French German Greek Hungarian Italian Latvian Lithuanian Macedonian Norwegian Portuguese Russian Slovak Slovenian Spanish Swedish Turkish Ukrainian

Go Back   Anabolic Steroids Discussion and Bodybuilding Forum > Anabolic Science Section > Anabolic Science Forum

Reply
 
LinkBack Thread Tools Display Modes
Interesting Tamoxifin article
Old
  (#1)
tee
AnaSCI VET
 
tee's Avatar
 
Offline
Posts: 4,130
Join Date: Feb 2004
Location: USA
Interesting Tamoxifin article - 07-04-2005, 08:21 PM

This is an abstract from a study done using tamoxifen on established cases of gynecomastia, of specific interest here men who had already developed lumps in their nipples prior to treatment. The study showed a 100% success rate in resolving (IE getting rid of) lumps in the breast. The success rate was not as good however in fatty-deposit gynecomastia.

Reference: Journal of Surgery (John Wiley & Sons Ltd); Jun2003 Supplement 1, Vol. 90 Issue 6, p100, 1/3p

Abstract: Aims: Physiological gynaecomastia can cause considerable psychological morbidity. We aimed to confirm recent suggestions that tamoxifen therapy alone may resolve this condition. Methods: All men referred from January to December 2002 with gynaecomastia had clinical signs recorded such as type, i.e. diffuse fatty or retro-areolar lump and size, together with possible aetiology. If clinical examination was inconclusive, histological diagnosis was sought. Patients with gynaecomastia were offered oral tamoxifen 20 mg once daily for 6 to 12 weeks. On follow-up patients were assessed for complete resolution (CR), partial resolution where the patient was satisfied with outcome (PR) or no resolution (NR). A successful outcome was regarded as either CR or PR. Results: Thirty-six men were given tamoxifen for physiological gynaecomastia. All completed the course and none were lost to follow up. Median age of patients was 31 (range 18-64). Median duration of gynaecomastia prior to diagnosis was 4 months (1-120). Tenderness was a feature in 25 (71%) cases. Sixteen men (45%) had fatty gynaecomastia whilst the remainder had lump gynaecomastia. Median tamoxifen duration was for 12 weeks (4-12). For lump gynaecomastia, there was a 100% (n = 20) successful outcome in terms of resolution of the lump and tenderness. However this decreased to 62 % (n = 10) success for resolution of fatty gynaecomastia and its associated tenderness. Only one case recurred after 7 months. Conclusions: Oral tamoxifen is a very effective treatment for physiological gynaecomastia and its associated tenderness. This effect is most marked for those with a retro-areolar lump gynaecomastia.
   
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On



All times are GMT -4. The time now is 06:22 PM.



Content Relevant URLs by vBSEO 3.6.0
Copyright © 2003-2019 AnaSCI.org. All rights reserved.